Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 64

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 64
---
 |     |           |     5,117,807799,366 |   |     |                       |   6,717,8097,891,942 |   |
| Total capitalization                                                                                                                                                                                                                                 |     |                                     |  5,123,55511,367,741 |   |     |           | 17,723,05724,595,169 |   |     |                       | 17,723,05725,087,743 |   |

| (1) | Pro forma additional paid in capital reflects the net proceeds we expect to receive, after deducting underwriting fee, underwriter expense allowance and other expenses. We expect to receive net proceeds of approximately $10,999,50012,120,000 (offering proceeds of $12,15013,500,000, less underwriting discounts of $850,500945,000, non-accountable expense of $93135,000 and offering expenses of $207300,000 which $263,194 have paid). The shares of Common Stock reflects the issuance and sale of 2,7003,000,000 shares of Common Stock at an assumed initial public offering price of $4.50 per share after deducting underwriting discounts, Underwriter expense allowance and other expenses.                                                                                                                                                                                                                |
| (2) | Pro forma as adjusted additional paid in capital reflects the net proceeds we expect to receive, after deducting underwriting fee, underwriter expense allowance and other expenses. We expect to receive net proceeds of approximately $12,599,50213,720,002 (offering proceeds of $12,15013,500,000 plus the total consideration of $1,600,002 to be paid for the conversion of the Convertible Notes, less underwriting discounts of $850,500945,000, non-accountable expense of $93135,000 and offering expenses of $207300,000 which $263,194 have paid). The shares of Common Stock reflects the (i) issuance and sale of 2,7003,000,000 shares of Common Stock at an assumed initial public offering price of $4.50 per share and (ii) issuance and sales of 1,066,668 shares of Common Stock at an assumed price of $1.50 after deducting underwriting discounts, Underwriter expense allowance and other expenses. |

| 38 |

<div align='center'>DILUTION</div>

If you invest in our Shares, your interest will be
diluted